The pharmaceutical and biopharma industries are in an era of transformation. The industry is growing rapidly, the demand for pharmaceuticals is increasing, new technologies are emerging, and there is more investment funding than ever. With this much growth and change, manufacturers are feeling pressure to operate in ways that allow them to keep up with both demand and operational changes.
And it’s even more challenging as a Tier 2 or Tier 3 firm. You’re facing the pressure to operate at enterprise scale without enterprise resources. Once a drug gets approved, scaling up to commercial production as quickly as possible becomes the goal – and it’s a demanding one. Relying on manual paper-based processes might have worked in the past, but with growing needs for agility, it’s no longer dependable.
If your goal is to scale production without sacrificing product quality, you need modern and digital solutions that can help you take advantage of this opportunity to grow. But what does success look like in the highly competitive and strongly regulated pharmaceutical industry?
Pressures abound
According to the Beyond Compliance: The Evolution of Pharmaceutical MES eBook, it involves achieving a balance that allows you to be swift and lean in your operations, yet robust in how you respond to changing market and regulatory forces. Finding this balance is increasingly grueling as challenges come at you from every direction.
- Your speed to market is more important than ever to reach new emerging markets, compete with generics and get the most out of products before their patents expire.
- Harnessing the power of integrated control and information system is required to build The Connected Enterprise® and attain organization-wide connectivity, and visibility is needed to align local operations with global requirements and improve efficiencies across plants.
- Maintaining competitive pricing is critical as nations around the world undergo varying degrees of health reform aiming to contain costs.
- Achieving compliant operations is non-negotiable yet increasingly complex in the global arena.
- Adopting a serialization strategy is a necessity to combat global counterfeiting in your supply chain and in the marketplace, and to comply with new anti-counterfeiting regulations.
- Versatile and responsive operations are required to serve the needs of an aging global population and the growing number of middle-class households in Asia and elsewhere.
Finding the right formula
Do you see challenges like expedited drug approvals, personalized medicines, workforce shortages and regulatory compliance? Don’t miss our webinar “MES for Life Sciences: Managing Production Complexity.” From improving quality and compliance, to maximizing production efficiency and speeding time to market, uncover how FactoryTalk® PharmaSuite® can help you lay the foundation to accelerate growth.
